Clinical trial
hsCRP in Japan Statin Treatment Against Recurrent Stroke (J-STARS hsCRP)
NCT00361699 · Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan, Other · Completed
Key facts
| NCT number | NCT00361699 |
|---|---|
| Title | hsCRP in Japan Statin Treatment Against Recurrent Stroke (J-STARS hsCRP) |
| Official title | Effect of 3-hydroxy-3-methylglutaryl-coenzyme A(HMG-CoA) Reductase Inhibitor Upon the Serum High Sensitive CRP in the Post-ischemic Patients With Hyperlipidemia During the Prospective Study of J-STARS. |
| Lead sponsor | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan, Other |
| Collaborators | Ministry of Health, Labour and Welfare, Japan Hiroshima University Osaka University |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ischemic Stroke |
| Intervention type | Drug |
| Interventions | Statin |
| Enrollment | 1,095 |
| Start date | Mar 1, 2004 |
| Primary completion | Jul 1, 2014 |
| First posted | Aug 8, 2006 |
| Last update posted | Apr 25, 2016 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: